MicroRNA expression profiling in clear cell renal cell carcinoma: Identification and functional validation of key miRNAs

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  He, Haowei ^a   Wang, Linhui ^b   Zhou, Wenquan ^a   Zhang, Zhengyu ^a   Wang, Longxin ^a   Xu, Song ^a   Wang, Dong ^a   Dong, Jie ^a   Tang, Chaopeng ^a   Tang, Hao ^a   Yi, Xiaoming ^a   Ge, Jingping ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 125B; MICRORNA 142 3P; MICRORNA 199A 5P; MICRORNA 22; MICRORNA 299 3P; MICRORNA 29A; MICRORNA 429; MICRORNA 452; MICRORNA 487A; MICRORNA 491 3P; MICRORNA 532 5P; TRANSCRIPTION FACTOR JUNB; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; UNCLASSIFIED DRUG; TUMOR PROTEIN;

ARTICLE; CELL INVASION; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION PROFILING; HEK293 CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CARCINOMA; MICROARRAY ANALYSIS; RENAL CANCER CELL LINE; UPREGULATION; DNA MICROARRAY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; KIDNEY TUMOR; METABOLISM; REPRODUCIBILITY; TUMOR CELL LINE; TUMOR INVASION;

CARCINOMA, RENAL CELL; CELL LINE, TUMOR; DOWN-REGULATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HUMANS; KIDNEY NEOPLASMS; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REPRODUCIBILITY OF RESULTS;

EID: 84929120362     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0125672     Document Type: Article

References (45)

1. Gupta K, Miller JD, Li JZ, Russell MW, Charbonneau C. Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review. Cancer Treat Rev. 2008; 34: 193-205. doi: 10.1016/j.ctrv.2007.12.001 PMID: 18313224
2. Patard JJ, Leray E, Rioux-Leclercq N, Cindolo L, Ficarra V, Zisman A, et al. Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience. J Clin Oncol. 2005; 23: 2763-2771. PMID: 15837991
3. Schachter LR, Cookson MS, Chang SS, Smith JA Jr, Dietrich MS, Jayaram G, et al. Second prize: frequency of benign renal cortical tumors and histologic subtypes based on size in a contemporary series: what to tell our patients. J Endourol. 2007; 21: 819-823. PMID: 17867935
4. Cheville JC, Lohse CM, Zincke H, Weaver AL, Blute ML. Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol. 2003; 27: 612-624. PMID: 12717246
5. Gudbjartsson T, Hardarson S, Petursdottir V, Thoroddsen A, Magnusson J, Einarsson GV. Histological subtyping and nuclear grading of renal cell carcinoma and their implications for survival: a retrospective nation-wide study of 629 patients. Eur Urol. 2005; 48: 593-600. PMID: 15964127
6. Taccoen X, Valeri A, Descotes JL, Morin V, Stindel E, Doucet L, et al. Renal cell carcinoma in adults 40 years old or less: young age is an independent prognostic factor for cancer-specific survival. Eur Urol. 2007 51: 980-987. PMID: 17092632
7. Vaziri SA, Grabowski DR, Hill J, Rybicki LR, Burk R, Bukowski RM, et al. Inhibition of proteasome activity by bortezomib in renal cancer cells is p53 dependent and VHL independent. Anticancer Res. 200929: 2961-2969.
8. Rini BI, Rathmell WK, Godley P. Renal cell carcinoma. Curr Opin Oncol. 2008; 20: 300-306. doi: 10.1097/CCO.0b013e3282f9782b PMID: 18391630
9. Coppin C, Kollmannsberger C, Le L, Porzsolt F, Wilt TJ. Targeted therapy for advanced renal cell cancer (RCC): a Cochrane systematic review of published randomised trials. BJU Int. 2011; 108: 1556-1563. doi: 10.1111/j.1464-410X.2011.10629.x PMID: 21952069
10. Bushati N, Cohen SM. microRNA functions. Annu Rev Cell Dev Biol. 2007; 23: 175-205. PMID: 17506695
11. Meola N, Gennarino VA, Banfi S. microRNAs and genetic diseases. Pathogenetics. 2009; 2: 7. doi: 10.1186/1755-8417-2-7 PMID: 19889204
12. Visone R, Croce CM. MiRNAs and cancer. Am J Pathol. 2009; 174: 1131-1138. doi: 10.2353/ajpath.2009.080794 PMID: 19264914
13. Nakada C, Matsuura K, Tsukamoto Y, Tanigawa M, Yoshimoto T, Narimatsu T, et al. Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c. J Pathol. 2008; 216: 418-427. doi: 10.1002/path.2437 PMID: 18925646
14. Huang Y, Dai Y, Yang J, Chen T, Yin Y, Tang M, et al. Microarray analysis of microRNA expression in renal clear cell carcinoma. Eur J Surg Oncol. 2009; 35: 1119-1123. doi: 10.1016/j.ejso.2009.04.010 PMID: 19443172
15. Petillo D, Kort EJ, Anema J, Furge KA, Yang XJ, Teh BT. MicroRNA profiling of human kidney cancer subtypes. Int J Oncol. 2009; 35: 109-114. PMID: 19513557
16. Chow TF, Youssef YM, Lianidou E, Romaschin AD, Honey RJ, Stewart R, et al. Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis. Clin Biochem. 2010; 43: 150-158. doi: 10.1016/j.clinbiochem.2009.07.020 PMID: 19646430
17. Fridman E, Dotan Z, Barshack I, David MB, Dov A, Tabak S, et al. Accurate molecular classification of renal tumors using microRNA expression. J Mol Diagn; 2010; 12: 687-696. doi: 10.2353/jmoldx.2010.090187 PMID: 20595629
18. Youssef YM, White NM, Grigull J, Krizova A, Samy C, Mejia-Guerrero S, et al. Accurate molecular classification of kidney cancer subtypes using microRNA signature. Eur Urol. 2011; 59: 721-730. doi: 10.1016/j.eururo.2011.01.004 PMID: 21272993
19. Wu X, Weng L, Li X, Guo C, Pal SK, Jin JM, et al. Identification of a 4-microRNA signature for clear cell renal cell carcinoma metastasis and prognosis. PLoS One. 2012; 7: e35661. doi: 10.1371/journal.pone.0035661 PMID: 22623952
20. Yi Z, Fu Y, Zhao S, Zhang X, Ma C. Differential expression of miRNA patterns in renal cell carcinoma and nontumorous tissues. J Cancer Res Clin Oncol. 2010; 136: 855-862. doi: 10.1007/s00432-009-0726-x PMID: 19921256
21. White NM, Bao TT, Grigull J, Youssef YM, Girgis A, Diamandis M, et al. miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation. J Urol. 2011; 186: 1077-1083. doi: 10.1016/j.juro.2011.04.110 PMID: 21784468
22. Jung M, Mollenkopf HJ, Grimm C, Wagner I, Albrecht M, Waller T, et al. MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy. J Cell Mol Med. 2009; 13: 3918-3928. doi: 10.1111/j.1582-4934.2009.00705.x PMID: 19228262
23. Huang X, Ding L, Bennewith KL, Tong RT, Welford SM, Ang KK, et al. Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation. Mol Cell. 2009; 35: 856-867. doi: 10.1016/j.molcel.2009.09.006 PMID: 19782034
24. Chow TF, Mankaruos M, Scorilas A, Youssef Y, Girgis A, Mossad S, et al. The miR-17-92 cluster is over expressed in and has an oncogenic effect on renal cell carcinoma. J Urol. 2010; 183: 743-751. doi: 10.1016/j.juro.2009.09.086 PMID: 20022054
25. Valera VA, Walter BA, Linehan WM, Merino MJ. Regulatory Effects of microRNA-92 (miR-92) on VHL Gene Expression and the Hypoxic Activation of miR-210 in Clear Cell Renal Cell Carcinoma. J Cancer. 2011; 2: 515-526. PMID: 22043236
26. Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol. 1982; 6: 655-663. PMID: 7180965
27. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell. 2007; 27: 91-105. PMID: 17612493
28. Goncalves JP, Francisco AP, Mira NP, Teixeira MC, Sa-Correia I, Oliveira AL, et al. TFRank: networkbased prioritization of regulatory associations underlying transcriptional responses. Bioinformatics. 2011; 27: 3149-3157. doi: 10.1093/bioinformatics/btr546 PMID: 21965816
29. Peirson SN, Butler JN, Foster RG. Experimental validation of novel and conventional approaches to quantitative real-time PCR data analysis. Nucleic Acids Res. 2003; 31: e73. PMID: 12853650
30. Shen WW, Zeng Z, Zhu WX, Fu GH. MiR-142-3p functions as a tumor suppressor by targeting CD133, ABCG2, and Lgr5 in colon cancer cells. J Mol Med. 2013; 91: 989-1000. doi: 10.1007/s00109-013-1037-x PMID: 23619912
31. Heinzelmann J, Henning B, Sanjmyatav J, Posorski N, Steiner T, Wunderlich H, et al. Specific miRNA signatures are associated with metastasis and poor prognosis in clear cell renal cell carcinoma. World J Urol. 2011; 29: 367-373. doi: 10.1007/s00345-010-0633-4 PMID: 21229250
32. Zhu XC, Dong QZ, Zhang XF, Deng B, Jia HL, Ye QH, et al. microRNA-29a suppresses cell proliferation by targeting SPARC in hepatocellular carcinoma. Int J Mol Med. 2012; 30: 1321-1326. doi: 10.3892/ijmm.2012.1140 PMID: 23023935
33. Zhu C, Wang Y, Kuai W, Sun X, Chen H, Hong Z. Prognostic value of miR-29a expression in pediatric acute myeloid leukemia. Clin Biochem. 2013; 46: 49-53. doi: 10.1016/j.clinbiochem.2012.09.002 PMID: 22981932
34. Su SF, Chang YW, Andreu-Vieyra C, Fang JY, Yang Z, Han B, et al. miR-30d, miR-181a and miR-199a-5p cooperatively suppress the endoplasmic reticulum chaperone and signaling regulator GRP78 in cancer. Oncogene. 2013; 32:4694-701. doi: 10.1038/onc.2012.483 PMID: 23085757
35. Guo MM, Hu LH, Wang YQ, Chen P, Huang JG, Lu N, et al. miR-22 is down-regulated in gastric cancer, and its overexpression inhibits cell migration and invasion via targeting transcription factor Sp1. Med Oncol. 2013; 30: 542. doi: 10.1007/s12032-013-0542-7 PMID: 23529765
36. Li B, Song Y, Liu TJ, Cui YB, Jiang Y, Xie ZS, et al. miRNA-22 suppresses colon cancer cell migration and invasion by inhibiting the expression of T-cell lymphoma invasion and metastasis 1 and matrix metalloproteinases 2 and 9. Oncol Rep. 2013; 29: 1932-1938. doi: 10.3892/or.2013.2300 PMID: 23440286
37. Liu D, Xia P, Diao D, Cheng Y, Zhang H, Yuan D, et al. MiRNA-429 suppresses the growth of gastric cancer cells in vitro. J Biomed Res. 2012; 26: 389-393. doi: 10.7555/JBR.26.20120029 PMID: 23554776
38. Sun T, Wang C, Xing J, Wu D. miR-429 modulates the expression of c-myc in human gastric carcinoma cells. Eur J Cancer. 2011; 47: 2552-2559. doi: 10.1016/j.ejca.2011.05.021 PMID: 21684154
39. Rosman DS, Phukan S, Huang CC, Pasche B. TGFBR1∗6A enhances the migration and invasion of MCF-7 breast cancer cells through RhoA activation. Cancer Res. 2008; 68: 1319-1328. doi: 10.1158/0008-5472.CAN-07-5424 PMID: 18316594
40. Wang LK, Hsiao TH, Hong TM, Chen HY, Kao SH, Wang WL, et al. MicroRNA-133a suppresses multiple oncogenic membrane receptors and cell invasion in non-small cell lung carcinoma. PLoS One. 2014 May 9; 9(5):e96765. doi: 10.1371/journal.pone.0096765 PMID: 24816813
41. Kanno T, Kamba T, Yamasaki T, Shibasaki N, Saito R, Terada N, et al. JunB promotes cell invasion and angiogenesis in VHL-defective renal cell carcinoma. Oncogene. 2012; 31: 3098-3110. doi: 10.1038/onc.2011.475 PMID: 22020339
42. Kong Y, Bai PS, Sun H, Nan KJ, Chen NZ, Qi XG. The deoxycholic acid targets miRNA-dependent CAC1 gene expression in multidrug resistance of human colorectal cancer. Int J Biochem Cell Biol. 2012; 44: 2321-2332. doi: 10.1016/j.biocel.2012.08.006 PMID: 22903020
43. Huang L, Lin JX, Yu YH, Zhang MY, Wang HY, Zheng M. Downregulation of six microRNAs is associated with advanced stage, lymph node metastasis and poor prognosis in small cell carcinoma of the cervix. PLoS One. 2012; 7: e33762. doi: 10.1371/journal.pone.0033762 PMID: 22438992
44. Shen Q, Cicinnati VR, Zhang X, Iacob S, Weber F, Sotiropoulos GC, et al. Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasion. Mol Cancer. 2010; 9: 227. doi: 10.1186/1476-4598-9-227 PMID: 20799954
45. Wang W, Zhao LJ, Tan YX, Ren H, Qi ZT. Identification of deregulated miRNAs and their targets in hepatitis B virus-associated hepatocellular carcinoma. World J Gastroenterol. 2012; 18: 5442-5453. doi: 10.3748/wjg.v18.i38.5442 PMID: 23082062